AbbVie (ABBV) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: January 25, 2022 7:26


AbbVie stock price online today

Analyst Target Price

137.37

Dividend Date

15.02.2022

Ex Dividend Date

13.01.2022

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell AbbVie stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2021, 2023, 2024?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $137.37 target price for AbbVie stock stock.

Today 200 Day Moving Average is the resistance level (115.52 $).

50 Day Moving Average is the resistance level (123.83 $).




AbbVie stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
27 Jan 22 132.80 131.50 134.47 2.26 %
28 Jan 22 131.87 131.11 133.74 2.01 %
29 Jan 22 133.08 132.05 134.10 1.55 %
30 Jan 22 132.10 129.99 132.76 2.13 %
31 Jan 22 133.10 131.37 134.14 2.11 %
01 Feb 22 132.81 131.93 134.43 1.89 %
02 Feb 22 132.94 131.99 134.64 2.01 %
03 Feb 22 132.76 132.20 134.40 1.67 %
04 Feb 22 132.52 131.40 133.84 1.86 %
05 Feb 22 130.82 129.25 132.42 2.45 %
06 Feb 22 128.73 128.19 129.94 1.37 %
07 Feb 22 128.57 126.93 130.40 2.73 %
08 Feb 22 128.55 126.62 129.58 2.34 %
09 Feb 22 129.35 128.00 130.15 1.68 %
10 Feb 22 130.64 128.65 131.53 2.23 %
11 Feb 22 132.42 131.57 133.02 1.11 %
12 Feb 22 134.59 132.68 136.61 2.96 %
13 Feb 22 133.67 132.39 135.01 1.98 %
14 Feb 22 132.63 131.75 134.59 2.15 %
15 Feb 22 133.74 132.89 135.19 1.73 %
16 Feb 22 134.57 132.66 136.08 2.58 %
17 Feb 22 135.57 134.54 136.57 1.51 %
18 Feb 22 136.30 134.12 137.25 2.34 %
19 Feb 22 138.29 136.88 140.17 2.40 %
20 Feb 22 139.78 139.22 141.18 1.41 %
21 Feb 22 142.41 140.33 143.38 2.17 %
22 Feb 22 141.19 139.04 142.99 2.84 %
23 Feb 22 141.70 140.25 142.80 1.82 %
24 Feb 22 140.19 139.18 142.04 2.05 %
25 Feb 22 141.40 139.36 142.28 2.09 %

ABBV daily forecast for this month


AbbVie stock forecast for 27.01.2022.
Estimated Average Forecasted AbbVie Price: 132.80 Positive intraday dynamics of the instrument is expected with 2.212% volatility is expected.

Pessimistic forecast: 131.50

Optimistic: 134.47


AbbVie stock forecast for 28.01.2022.
Estimated Average Forecasted AbbVie Price: 131.87 Negative intraday dynamics of the instrument is expected with 1.972% volatility is expected.

Pessimistic forecast: 131.11

Optimistic: 133.74


AbbVie stock forecast for 29.01.2022.
Estimated Average Forecasted AbbVie Price: 133.08 Positive intraday dynamics of the instrument is expected with 1.529% volatility is expected.

Pessimistic forecast: 132.05

Optimistic: 134.10


AbbVie stock forecast for 30.01.2022.
Estimated Average Forecasted AbbVie Price: 132.10 Negative intraday dynamics of the instrument is expected with 2.090% volatility is expected.

Pessimistic forecast: 129.99

Optimistic: 132.76


AbbVie stock forecast for 31.01.2022.
Estimated Average Forecasted AbbVie Price: 133.10 Positive intraday dynamics of the instrument is expected with 2.064% volatility is expected.

Pessimistic forecast: 131.37

Optimistic: 134.14


ABBV Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Feb 136.31 132.49 138.92 4.63 %
Mar 141.87 134.94 146.63 7.97 %
Apr 138.58 134.81 144.34 6.61 %
May 135.58 129.72 143.83 9.80 %
Jun 130.70 128.30 137.08 6.41 %
Jul 127.77 123.68 133.09 7.07 %
Aug 127.77 122.66 130.64 6.10 %
Sep 132.48 127.60 137.35 7.10 %
Oct 129.40 127.02 132.51 4.14 %
Nov 119.36 115.83 123.37 6.11 %
Dec 121.94 115.11 128.47 10.40 %

AbbVie stock forecast for this year


AbbVie share price average forecast for Feb 2022 is: 136.305 The dynamics are positive.
AbbVie share price average forecast for Mar 2022 is: 141.866 The dynamics are positive.
AbbVie share price average forecast for Apr 2022 is: 138.575 The dynamics are negative.
AbbVie share price average forecast for May 2022 is: 135.582 The dynamics are negative.
AbbVie share price average forecast for Jun 2022 is: 130.701 The dynamics are negative.
AbbVie share price average forecast for Jul 2022 is: 127.773 The dynamics are negative.
AbbVie share price average forecast for Aug 2022 is: 127.773 The dynamics are negative.
AbbVie share price average forecast for Sep 2022 is: 132.475 The dynamics are positive.
AbbVie share price average forecast for Oct 2022 is: 129.402 The dynamics are negative.
AbbVie share price average forecast for Nov 2022 is: 119.36 The dynamics are negative.
AbbVie share price average forecast for Dec 2022 is: 121.938 The dynamics are positive.


AbbVie stock Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 124.87 121.97 131.16 7.01 %
Feb 120.97 117.58 127.26 7.60 %
Mar 117.39 111.66 121.80 8.33 %
Apr 113.54 107.27 120.53 11.00 %
May 117.44 110.49 124.30 11.11 %
Jun 126.37 123.13 133.75 7.94 %
Jul 130.51 128.11 135.74 5.62 %
Aug 128.01 124.32 135.28 8.10 %
Sep 121.97 114.55 128.11 10.59 %
Oct 113.97 106.76 121.08 11.82 %
Nov 109.95 105.73 115.94 8.80 %
Dec 113.30 109.76 117.01 6.20 %

AbbVie stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 121.45 115.24 126.31 8.77 %
Feb 119.80 116.26 122.58 5.16 %
Mar 118.75 111.81 124.73 10.36 %
Apr 124.45 118.67 126.94 6.51 %
May 128.23 124.95 135.72 7.94 %
Jun 121.87 114.27 129.57 11.81 %
Jul 124.50 118.03 130.68 9.68 %
Aug 119.12 113.88 122.46 7.00 %
Sep 118.74 115.42 123.68 6.68 %
Oct 127.10 122.43 129.85 5.72 %
Nov 122.02 119.38 125.34 4.75 %
Dec 122.80 118.18 129.09 8.45 %



AbbVie stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 117.89 113.74 120.72 5.78 %
Feb 121.94 119.31 125.94 5.27 %
Mar 122.04 118.14 127.80 7.56 %
Apr 131.80 124.84 138.76 10.03 %
May 132.23 126.73 136.25 6.99 %
Jun 121.75 116.20 126.33 8.02 %
Jul 117.08 114.17 120.45 5.21 %
Aug 115.95 108.53 118.18 8.16 %
Sep 124.30 119.93 129.08 7.09 %
Oct 129.18 126.70 134.96 6.13 %
Nov 135.58 128.86 142.52 9.59 %
Dec 135.15 128.66 141.85 9.30 %

AbbVie stock Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 138.18 134.42 145.25 7.46 %
Feb 142.16 138.63 144.77 4.24 %
Mar 142.38 134.75 144.78 6.92 %
Apr 149.33 140.13 153.99 9.00 %
May 144.91 137.03 152.91 10.39 %
Jun 146.19 140.11 154.02 9.04 %
Jul 147.47 142.64 153.96 7.36 %
Aug 144.76 138.97 149.97 7.34 %
Sep 145.80 141.60 151.28 6.40 %
Oct 148.60 141.82 157.52 9.96 %
Nov 160.13 156.80 163.34 4.00 %
Dec 163.21 157.07 170.65 7.96 %

AbbVie overview

AbbVie Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Market Capitalization

241 121 149 000 $

EBITDA

28 854 999 000

PE Ratio

32.5

PEG Ratio

1.279

Dividend Per Share

5.2

Dividend Yield

0.0418

EPS

4.196

Quarterly Earnings Growth YOY

0.38

Quarterly Revenue Growth YOY

0.112

Trailing PE

32.5

Forward PE

8.95

EV To Revenue

5.26

EV To EBITDA

15.87

52 Week High

138.15

52 Week Low

98.29

50 Day Moving Average

123.83

200 Day Moving Average

115.52

Shares Outstanding

1767880000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 123.82 (24.01.2022) -1.60 %
AbbVie Inc.
ABBV 131.98 (21.01.2022) -0.79 %
Aeterna Zentaris Inc.
AEZS 0.3434 (24.01.2022) 4.12 %
Allakos Inc.
ALLK 6.81 (24.01.2022) -0.58 %
Allogene Therapeutics, Inc.
ALLO 11.34 (24.01.2022) -0.18 %
Amgen Inc.
AMGN 226.08 (24.01.2022) -0.72 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (24.01.2022) 4.79 %
Aurora Cannabis Inc.
ACB 4.32 (24.01.2022) -3.14 %
Becton Dickinson and Company
BDX 264.63 (21.01.2022) 0.25 %
Biogen Inc.
BIIB 220.52 (21.01.2022) -2.39 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 110.08 (21.01.2022) -5.10 %
BioNTech SE
BNTX 150.98 (24.01.2022) 2.36 %
bluebird bio, Inc.
BLUE 7.71 (24.01.2022) 6.49 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 62.61 (24.01.2022) -1.46 %
Canopy Growth Corp.
CGC 7.4 (24.01.2022) 1.51 %
Castle Biosciences, Inc.
CSTL 35.44 (24.01.2022) 5.48 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 240.42 (24.01.2022) -1.09 %
Emergent BioSolutions Inc.
EBS 46.97 (21.01.2022) 0.97 %
Exelixis, Inc.
EXEL 18.52 (24.01.2022) 6.93 %
G1 Therapeutics, Inc.
GTHX 8.98 (24.01.2022) 2.98 %
Gilead Sciences, Inc.
GILD 68.57 (24.01.2022) 0.09 %
GlaxoSmithKline plc
GSK 44.38 (24.01.2022) -1.60 %
GoodRx Holdings, Inc.
GDRX 24.23 (24.01.2022) 3.06 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.34 (24.01.2022) 0.74 %
Inovio Pharmaceuticals, Inc.
INO 3.92 (24.01.2022) 0.00 %
Johnson & Johnson
JNJ 162.97 (24.01.2022) -1.15 %
Medtronic plc.
MDT 104.21 (24.01.2022) -1.32 %
Merck & Co., Inc.
MRK 78.83 (24.01.2022) -1.44 %
Moderna, Inc.
MRNA 157.3 (24.01.2022) -1.73 %
Novartis AG
NVS 85.13 (24.01.2022) -2.18 %
Novavax, Inc.
NVAX 79.47 (24.01.2022) -6.12 %
ObsEva SA
OBSV 1.5 (24.01.2022) -11.24 %
OrganiGram Holdings Inc.
OGI 1.46 (24.01.2022) 1.39 %
Pfizer Inc.
PFE 51.54 (24.01.2022) -2.37 %
Regeneron Pharmaceuticals, Inc.
REGN 621.48 (24.01.2022) 0.01 %
Sanofi
SNY 50.84 (24.01.2022) -0.78 %
Schrodinger, Inc.
SDGR 27.97 (24.01.2022) 3.29 %
Senseonics Holdings, Inc.
SENS 2.38 (24.01.2022) -8.46 %
Sorrento Therapeutics, Inc.
SRNE 3.535 (24.01.2022) -7.10 %
Stryker Corp.
SYK 251.92 (24.01.2022) -1.08 %
Sundial Growers Inc.
SNDL 0.4783 (21.01.2022) -7.74 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.46 (24.01.2022) -0.59 %
Thermo Fisher Scientific Inc.
TMO 575.8 (24.01.2022) -0.78 %
Tilray, Inc.
TLRY 5.84 (24.01.2022) 0.86 %
UnitedHealth Group, Inc.
UNH 462.27 (24.01.2022) 0.24 %
Veeva Systems Inc.
VEEV 227.36 (24.01.2022) 2.38 %
Zomedica Corp.
ZOM 0.3 (24.01.2022) -0.03 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.5 (24.01.2022) 5.49 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.